SAT0454 In primary sjÖgren's syndrome blood cd180-negative b cells are increased in patients with high systemic disease activity
Renaud Felten(Centre National de la Recherche Scientifique), Jacques‐Eric Gottenberg(Centre National de la Recherche Scientifique), Laurent Mauvieux(Centre National de la Recherche Scientifique), Emmanuel Chatelus(Laboratoire National de Référence), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), Laurent Arnaud(Université Libre de Bruxelles), Caroline Mayeur‐Rousse, H. Petit(Hôpitaux Universitaires de Strasbourg), R.‐M. Javier(Hôpitaux Universitaires de Strasbourg), Laurent Miguet(Hôpital d'Hautepierre), Luc Matthieu Fornecker(Hôpital d'Hautepierre), Christelle Sordet
Cited by 0
Related Papers
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
|Annals of the Rheumatic Diseases|2016|355